Role of Ellagic Acid against Cisplatin‐Induced Nephrotoxicity and Oxidative Stress in Rats
- 6 December 2006
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 100 (2), 121-126
- https://doi.org/10.1111/j.1742-7843.2006.00015.x
Abstract
The aim of this study was to investigate the possible protective role of antioxidant treatment with ellagic acid on cisplatin-induced nephrotoxicity using biochemical and histopatological approaches. Adult male Sprague-Dawley rats were randomly divided into four groups. The control group received 0.9% saline; animals in the ellagic acid group received only ellagic acid (10 mg/kg); animals in the cisplatin group received only cisplatin (7 mg/kg); animals in the cisplatin + ellagic acid group received ellagic acid for 10 days after cisplatin. The effects of ellagic acid on cisplatin-induced nephrotoxicity were evaluated by plasma creatinine, urea, sodium and calcium concentrations; kidney tissue malondialdehyde, reduced glutathione (GSH), glutathione peroxidase (GSH peroxidase) and catalase activities and histopatological examinations. Administration of cisplatin to rats induced a marked renal failure, characterized by significant increases in plasma creatinine, urea and calcium concentrations. Cisplatin also induced oxidative stress, as indicated by increased kidney tissue concentrations of malondialdehyde, and reduced activities of GSH peroxidase and catalase. Furthermore, treatment with cisplatin caused a marked tubular necrosis, degeneration and desquamation, luminal cast formation, karyomegaly, tubular dilatation, interstitial mononuclear cell infiltration and inter-tubular haemorrhagia. Ellagic acid markedly reduced elevated plasma creatinine, urea and calcium levels and counteracted the deleterious effects of cisplatin on oxidative stress markers. In the same way, ellagic acid ameliorated cisplatin-induced pathological changes including tubular necrosis, degeneration, karyomegaly, tubular dilatation when compared to the cisplatin alone group. These results indicate that the antioxidant ellagic acid might have a protective effect against cisplatin-induced nephrotoxicity and oxidative stress in rat, but not enough to inhibit cisplatin-induced renal dysfunction.Keywords
This publication has 37 references indexed in Scilit:
- Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicityToxicology, 2006
- Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in ratsToxicology, 2005
- In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juiceThe Journal of Nutritional Biochemistry, 2005
- Bioactive Compounds from the Seeds of Punica granatum (Pomegranate)Journal of Natural Products, 2004
- Kidney Slices of Human and Rat to Characterize Cisplatin-Induced Injury on Cellular Pathways and MorphologyToxicologic Pathology, 2004
- The effects of oral glutamine on cisplatin-induced nephrotoxicity in ratsPharmacological Research, 2003
- Inhibitory effects of ellagic acid on the direct-acting mutagenicity of aflatoxin B1 in the Salmonella microsuspension assayMutation Research, 1998
- Mechanism of Protection by Diethyldithiocarbamate against Cisplatin Ototoxicity: Antioxidant SystemFundamental and Applied Toxicology, 1995
- Glutathione peroxidase activity in selenium-deficient rat liverBiochemical and Biophysical Research Communications, 1976